- Home
- IMA vs ZTEK Comparison
IMA vs ZTEK Comparison
Compare IMA & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMA
- ZTEK
- Stock Information
- Founded
- IMA 2019
- ZTEK 2008
- Country
- IMA United States
- ZTEK Canada
- Employees
- IMA N/A
- ZTEK N/A
- Industry
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- ZTEK Major Chemicals
- Sector
- IMA Health Care
- ZTEK Industrials
- Exchange
- IMA Nasdaq
- ZTEK Nasdaq
- Market Cap
- IMA 92.2M
- ZTEK 89.3M
- IPO Year
- IMA N/A
- ZTEK N/A
- Fundamental
- Price
- IMA $8.23
- ZTEK $0.76
- Analyst Decision
- IMA Buy
- ZTEK
- Analyst Count
- IMA 1
- ZTEK 0
- Target Price
- IMA $30.00
- ZTEK N/A
- AVG Volume (30 Days)
- IMA 68.3K
- ZTEK 66.5K
- Earning Date
- IMA 11-12-2025
- ZTEK 11-14-2025
- Dividend Yield
- IMA N/A
- ZTEK N/A
- EPS Growth
- IMA N/A
- ZTEK N/A
- EPS
- IMA N/A
- ZTEK N/A
- Revenue
- IMA $800,000.00
- ZTEK $657,134.00
- Revenue This Year
- IMA N/A
- ZTEK N/A
- Revenue Next Year
- IMA N/A
- ZTEK N/A
- P/E Ratio
- IMA N/A
- ZTEK N/A
- Revenue Growth
- IMA N/A
- ZTEK 2225.73
- 52 Week Low
- IMA $7.24
- ZTEK $0.62
- 52 Week High
- IMA $23.28
- ZTEK $1.84
- Technical
- Relative Strength Index (RSI)
- IMA N/A
- ZTEK 48.27
- Support Level
- IMA N/A
- ZTEK $0.78
- Resistance Level
- IMA N/A
- ZTEK $0.85
- Average True Range (ATR)
- IMA 0.00
- ZTEK 0.06
- MACD
- IMA 0.00
- ZTEK -0.01
- Stochastic Oscillator
- IMA 0.00
- ZTEK 35.74
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.